Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bay 12-9566
2. Bay 12-9566n
3. Bay 129566
4. Bay-12-9566
1. 179545-77-8
2. Bay 12-9566
3. Bay-12-9566
4. (s)-4-(4'-chloro-[1,1'-biphenyl]-4-yl)-4-oxo-2-((phenylthio)methyl)butanoic Acid
5. Am1zx94exh
6. Bay-129566
7. Chembl261932
8. (s)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic Acid
9. (2s)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic Acid
10. [1,1'-biphenyl]-4-butanoic Acid, 4'-chloro-gamma-oxo-alpha-[(phenylthio)methyl]-, (alphas)-
11. C23h19clo3s
12. Tanomastat [usan:inn]
13. Unii-am1zx94exh
14. (1,1'-biphenyl)-4-butanoic Acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (alphas)-
15. Tanomastat [inn]
16. Tanomastat (usan/inn)
17. Tanomastat [usan]
18. Tanomastat [who-dd]
19. Schembl153066
20. Bay12-9566
21. Gtpl6468
22. Bay 129566
23. Dtxsid60870145
24. Chebi:188765
25. Ex-a7633
26. Bay 12-9566n
27. Bdbm50084661
28. Akos015911399
29. Bay 12-9566 N
30. Db06276
31. (s)-4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1'-biphenyl)-4-butanoic Acid
32. Hy-12168
33. Cs-0003131
34. Ft-0674808
35. Ns00068311
36. C90420
37. D03802
38. (1,1'-biphenyl)-4-butanoic Acid, 4'-chloro-gamma-oxo-alpha-((phenylthio)methyl)-, (s)-
39. (2s)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulanylmethyl)butanoic Acid
40. (s)-3-((4'-chloro-4-biphenylyl)carbonyl)-2-((phenylthio)methyl)propionic Acid
41. (s)-4-(4'-chloro-[1,1'-biphenyl]-4-yl)-4-oxo-2-((phenylthio)methyl)butanoicacid
42. 4-(4''-chloro-biphenyl-4-yl)-4-oxo-2-phenylsulfanylmethyl-butyric Acid(bay-12-9566)
Molecular Weight | 410.9 g/mol |
---|---|
Molecular Formula | C23H19ClO3S |
XLogP3 | 5.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 79.7 |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 504 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in pancreatic cancer, lung cancer, ovarian cancer, and osteoarthritis.
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
VMF Number : 5732
Submission : 2001-11-30
Status : Active
Type : II
ABOUT THIS PAGE
86
PharmaCompass offers a list of Tanomastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tanomastat manufacturer or Tanomastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tanomastat manufacturer or Tanomastat supplier.
PharmaCompass also assists you with knowing the Tanomastat API Price utilized in the formulation of products. Tanomastat API Price is not always fixed or binding as the Tanomastat Price is obtained through a variety of data sources. The Tanomastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tanomastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tanomastat, including repackagers and relabelers. The FDA regulates Tanomastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tanomastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tanomastat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tanomastat supplier is an individual or a company that provides Tanomastat active pharmaceutical ingredient (API) or Tanomastat finished formulations upon request. The Tanomastat suppliers may include Tanomastat API manufacturers, exporters, distributors and traders.
click here to find a list of Tanomastat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tanomastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tanomastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tanomastat GMP manufacturer or Tanomastat GMP API supplier for your needs.
A Tanomastat CoA (Certificate of Analysis) is a formal document that attests to Tanomastat's compliance with Tanomastat specifications and serves as a tool for batch-level quality control.
Tanomastat CoA mostly includes findings from lab analyses of a specific batch. For each Tanomastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tanomastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Tanomastat EP), Tanomastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tanomastat USP).